{"cluster": 50, "subcluster": 17, "abstract_summ": "The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV\u20112 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful.We report a national case series of 11 virologically-confirmed COVID-19 patients having experienced a second clinically- and virologically-confirmed acute COVID-19 episode.Here we report the course of COVID-19 in a CLL patient with secondary immunodeficiency and viral co-infection with parainfluenza.We present a case series of 3 patients with coinfection of COVID-19 and influenza, with 2 of them treated successfully and discharged home.For the first 3 months of COVID-19 pandemic, COVID-19 was expected to be an immunizing non-relapsing disease.", "title_summ": "A Case Series of Patients Coinfected With Influenza and COVID-19Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020): Statement of the Austrian Society of Pneumology (ASP)Infant Case of Co-infection with SARS-CoV-2 and Citrobacter koseri Urinary InfectionClinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from ArgentinaCo-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case ReportCOVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.", "title_abstract_phrases": "Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020): Statement of the Austrian Society of Pneumology (ASP)The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide.Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from ArgentinaCoronavirus disease 2019 (COVID\u201019), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world.The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV\u20112 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful.Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case ReportCoronavirus 2 (SARS-CoV-2) is now considered a pandemic causing Coronavirus disease (COVID-19), multiple fatalities and morbidities which have been associated with it worldwide.We report a national case series of 11 virologically-confirmed COVID-19 patients having experienced a second clinically- and virologically-confirmed acute COVID-19 episode."}